查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1975117

核医设备市场分析及预测（至2035年）：依类型、产品类型、服务、技术、组件、应用、最终用户、安装类型、模式及阶段划分

Nuclear Medicine Equipment Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Installation Type, Mode, Stage
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计核医设备市场规模将从2025年的45亿美元成长到2035年的82亿美元，复合年增长率约为6.2%。 2025年市场规模预计为1,200台，2035年将达到2,000台。目前，单光子发射电脑断层扫描（SPECT）占最大的市场份额，达45%，其次是正子断层扫描（PET），占35%，混合影像系统占20%。 SPECT的领先地位得益于其成本效益以及在心臟病学和肿瘤学领域的广泛应用。市场上的主要企业包括西门子医疗、通用电气医疗和飞利浦医疗，它们在技术创新和市场扩张方面都发挥着重要作用。

竞争格局深受各公司策略倡议的影响，例如西门子医疗对人工智慧增强成像技术的投资以及通用电气医疗拓展其PET示踪剂产品组合。法规结构，特别是美国食品药物管理局管理局（FDA）和欧洲药品管理局（EMA）的指导方针，对强调合规性和创新性的市场运作有重大影响。未来预测显示，市场将维持强劲成长势头，预计2035年，研发投资的年增率将进一步提高。这一增长将由技术进步和慢性病患病率上升趋势驱动。然而，高成本和严格的监管核准等挑战依然存在。人工智慧和机器学习在诊断成像领域的应用有望透过提高诊断准确性和营运效率，开闢新的机会。

市场区隔
类型 SPECT影像系统、PET影像系统、平面闪烁显像、混合成像等。
产品 伽马摄影机、PET/CT扫描仪、SPECT/CT扫描仪、迴旋加速器、放射性药物等。
服务 设备维护、咨询、训练、安装、升级及其他服务。
科技 数位成像、类比成像、软体解决方案、放射性药物製造等。
成分 检测器、准直器、资料撷取系统、处理单元、显示器系统等。
应用领域 心臟病学、肿瘤学、神经病学、整形外科、内分泌学、肾臟病学、消化病学、呼吸内科及其他
最终用户 医院、诊断中心、研究机构、学术机构、专科诊所及其他
安装类型 新安装、维修安装及其他
模式 住院病人、门诊病人及其他
步 临床前阶段、临床阶段、商业化阶段、其他

核医设备市场正经历强劲成长，这主要得益于技术进步和对早期诊断日益增长的需求。单光子发射电脑断层扫描（SPECT）凭藉其在心臟病学和肿瘤学领域的广泛应用，引领市场。正子断层扫描（PET）是第二大细分市场，由于其在检测组织代谢变化方面的高精度，表现强劲。从区域来看，北美市场占据领先地位，这得益于其完善的医疗基础设施和先进技术的高普及率。欧洲位居第二，德国和英国由于医疗保健支出不断增长和活性化的研究投入，做出了显着贡献。在亚太地区，中国和印度正凭藉着医疗设施的扩张和人们对核子医学认知的提高，成为极具潜力的市场。战略合作和政府促进核子医学应用的政策进一步推动了市场成长。成像能力的提升和人工智慧在诊断中的应用，为相关人员创造了巨大的商机。

区域概览

北美地区，尤其是美国，在核医设备市场占据主导地位。美国先进的医疗基础设施和对研发的大量投入推动了市场成长。主要市场参与者的存在以及先进技术的高普及率进一步巩固了该地区的主导地位。

其次，欧洲地区以德国、法国和英国为主导，这三个国家是主要贡献者。这些国家拥有健全的医疗保健体系，并且高度重视技术创新。政府支持核子医学在诊断和治疗中应用的政策也扮演着至关重要的角色。

亚太地区市场正迅速扩张。中国和印度等国家对核医设备的需求不断增加。这一增长主要得益于医疗费用支出的增加以及人们对现代诊断技术的认知度提高。此外，政府为改善医疗基础设施所做的努力也显着促进了市场扩张。

拉丁美洲地区的核子医学设备市场展现出巨大的成长潜力。巴西和墨西哥处于领先地位，不断增加对医疗基础设施的投资。慢性病盛行率的上升以及对早期诊断需求的成长是该地区市场成长的关键驱动因素。

中东和非洲地区在核子医学设备市场的份额正稳定成长。阿联酋和南非是推动这一成长的主要力量。对医疗基础设施的投资以及对先进诊断技术的日益重视是这些地区市场发展的关键因素。

主要趋势和驱动因素

核医设备市场正经历强劲成长，这主要得益于影像技术的进步和慢性病盛行率的上升。人工智慧（AI）在诊断影像中的应用是关键趋势，它提高了诊断的准确性和效率。这项技术进步使得疾病的早期发现和个人化治疗方案的发展成为可能，从而推动了市场扩张。

人口老化和癌症发病率上升是推动市场成长的关键因素，也增加了对先进诊断解决方案的需求。政府和医疗机构加大对核医基础设施的投资，进一步加速了市场成长。此外，非侵入性诊断方法的普及也促进了对核医设备的需求。

随着医疗基础设施的不断完善，新兴市场蕴藏着丰富的机会。专注于提供高性价比创新解决方案的公司有望占据可观的市场份额。此外，研究机构与设备製造商之间的合作能够促进创新，确保市场持续发展并适应不断变化的医疗需求。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章：细分市场分析

  • 市场规模及预测：依类型
    • SPECT影像系统
    • PET影像系统
    • 平面闪烁显像
    • 混合成像
    • 其他的
  • 市场规模及预测：依产品划分
    • 伽马摄影机
    • PET/CT扫描仪
    • SPECT/CT扫描仪
    • 迴旋加速器
    • 放射性药物
    • 其他的
  • 市场规模及预测：依服务划分
    • 设备维护和检查
    • 咨询
    • 训练
    • 安装
    • 升级
    • 其他的
  • 市场规模及预测：依技术划分
    • 月球成像
    • 类比成像
    • 软体解决方案
    • 放射性药物生产
    • 其他的
  • 市场规模及预测：依组件划分
    • 检测器
    • 准直器
    • 数据采集系统
    • 处理单元
    • 显示系统
    • 其他的
  • 市场规模及预测：依应用领域划分
    • 心臟病学
    • 肿瘤学
    • 神经病学
    • 整形外科
    • 内分泌学
    • 肾臟病学
    • 胃肠病学
    • 肺科
    • 其他的
  • 市场规模及预测：依最终用户划分
    • 医院
    • 诊断中心
    • 研究机构
    • 学术机构
    • 专科诊所
    • 其他的
  • 市场规模及预测：依安装类型划分
    • 新推出
    • 改装安装
    • 其他的
  • 市场规模及预测：按模式
    • 住院病人
    • 门诊治疗
    • 其他的
  • 市场规模及预测：依疾病阶段划分
    • 临床前
    • 临床
    • 商业的
    • 其他的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Canon Medical Systems
  • Fujifilm Holdings Corporation
  • Hitachi Medical Systems
  • Shimadzu Corporation
  • Neusoft Medical Systems
  • Mediso Medical Imaging Systems
  • Digirad Corporation
  • SurgicEye
  • CMR Naviscan
  • DDD-Diagnostic
  • Sofie Biosciences
  • Medsight Technologies
  • Gamma Medica
  • Nordion
  • Biosensors International
  • Positron Corporation
  • Cardiarc

第九章 关于我们

简介目录
Product Code: GIS34459

The Nuclear Medicine Equipment Market is expected to expand from $4.5 billion in 2025 to $8.2 billion by 2035, with a CAGR of approximately 6.2%. In 2025, the Nuclear Medicine Equipment Market was estimated to have a volume of 1,200 units, with projections to reach 2,000 units by 2035. The Single Photon Emission Computed Tomography (SPECT) segment currently holds the largest market share at 45%, followed by Positron Emission Tomography (PET) at 35%, and hybrid imaging systems at 20%. The SPECT segment's dominance is driven by its cost-effectiveness and widespread application in cardiology and oncology. Key players in the market include Siemens Healthineers, GE Healthcare, and Philips Healthcare, each playing a pivotal role in advancing technology and expanding market reach.

The competitive landscape is heavily influenced by these companies' strategic initiatives, such as Siemens Healthineers' investment in AI-enhanced imaging and GE Healthcare's focus on expanding its PET tracer portfolio. Regulatory frameworks, particularly the FDA and European Medicines Agency guidelines, significantly impact market operations, emphasizing compliance and innovation. Future projections indicate a robust growth trajectory, with a higher annual increase in R&D investment anticipated by 2035. This growth is driven by technological advancements and an increasing prevalence of chronic diseases. However, challenges such as high equipment costs and stringent regulatory approvals remain. The integration of AI and machine learning in imaging is expected to unlock new opportunities, enhancing diagnostic accuracy and operational efficiency.

Market Segmentation
TypeSPECT Imaging Systems, PET Imaging Systems, Planar Scintigraphy, Hybrid Imaging, Others
ProductGamma Cameras, PET/CT Scanners, SPECT/CT Scanners, Cyclotrons, Radiopharmaceuticals, Others
ServicesEquipment Maintenance, Consulting, Training, Installation, Upgradation, Others
TechnologyDigital Imaging, Analog Imaging, Software Solutions, Radiopharmaceutical Production, Others
ComponentDetectors, Collimators, Data Acquisition Systems, Processing Units, Display Systems, Others
ApplicationCardiology, Oncology, Neurology, Orthopedics, Endocrinology, Nephrology, Gastroenterology, Pulmonology, Others
End UserHospitals, Diagnostic Centers, Research Institutes, Academic Institutions, Specialty Clinics, Others
Installation TypeNew Installation, Retrofit Installation, Others
ModeInpatient, Outpatient, Others
StagePreclinical, Clinical, Commercial, Others

The nuclear medicine equipment market is witnessing robust growth, driven by technological advancements and increasing demand for early diagnosis. The SPECT (Single Photon Emission Computed Tomography) segment dominates due to its widespread application in cardiology and oncology. PET (Positron Emission Tomography) follows as the second-highest performing sub-segment, benefiting from its precision in detecting metabolic changes in tissues. Among regions, North America leads the market, supported by a well-established healthcare infrastructure and high adoption of advanced technologies. Europe ranks second, with significant contributions from Germany and the UK, driven by rising healthcare expenditure and research activities. In Asia-Pacific, China and India are emerging as lucrative markets due to expanding healthcare facilities and increasing awareness about nuclear medicine. The market's growth is further fueled by strategic collaborations and government initiatives promoting the adoption of nuclear medicine. Enhanced imaging capabilities and the integration of AI in diagnostics present lucrative opportunities for stakeholders.

Geographical Overview

The North American region dominates the nuclear medicine equipment market, primarily driven by the United States. The countrya™s advanced healthcare infrastructure and significant investment in research and development propel market growth. The presence of key market players and a high adoption rate of advanced technologies further enhance this region's leading position.

Europe follows closely, with Germany, France, and the United Kingdom being major contributors. These countries have a robust healthcare system and a strong focus on technological advancements. Government initiatives supporting nuclear medicine applications in diagnostics and treatment also play a crucial role.

In the Asia Pacific, the market is rapidly expanding. Countries like China and India are witnessing increased demand for nuclear medicine equipment. This growth is driven by rising healthcare expenditures and a growing awareness of modern diagnostic techniques. Additionally, government efforts to improve healthcare infrastructure contribute significantly to the market's expansion.

Latin America shows promising growth potential in the nuclear medicine equipment market. Brazil and Mexico are at the forefront, with increasing investments in healthcare infrastructure. The rising prevalence of chronic diseases and a growing demand for early diagnosis are key factors driving market growth in this region.

The Middle East and Africa region is gradually emerging in the nuclear medicine equipment market. The United Arab Emirates and South Africa are leading this growth. Investments in healthcare infrastructure and an increasing focus on advanced diagnostic techniques are significant contributors to the market's development in these regions.

Key Trends and Drivers

The Nuclear Medicine Equipment Market is experiencing robust growth, propelled by advancements in imaging technologies and increased prevalence of chronic diseases. Key trends include the integration of artificial intelligence in diagnostic imaging, enhancing accuracy and efficiency. This technological evolution is enabling early disease detection and personalized treatment plans, driving market expansion.

The growing geriatric population and rising cancer incidence are significant drivers, necessitating advanced diagnostic solutions. Governments and healthcare institutions are investing in nuclear medicine infrastructure, further fueling market growth. Additionally, the shift towards non-invasive diagnostic procedures is boosting demand for nuclear medicine equipment.

Opportunities are abundant in emerging markets where healthcare infrastructure is expanding. Companies focusing on cost-effective and innovative solutions are poised to capture significant market share. Furthermore, collaborations between research institutions and equipment manufacturers are fostering innovation, ensuring the market's continuous evolution and adaptation to emerging healthcare needs.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Installation Type
  • 2.9 Key Market Highlights by Mode
  • 2.10 Key Market Highlights by Stage

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 SPECT Imaging Systems
    • 4.1.2 PET Imaging Systems
    • 4.1.3 Planar Scintigraphy
    • 4.1.4 Hybrid Imaging
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Gamma Cameras
    • 4.2.2 PET/CT Scanners
    • 4.2.3 SPECT/CT Scanners
    • 4.2.4 Cyclotrons
    • 4.2.5 Radiopharmaceuticals
    • 4.2.6 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Equipment Maintenance
    • 4.3.2 Consulting
    • 4.3.3 Training
    • 4.3.4 Installation
    • 4.3.5 Upgradation
    • 4.3.6 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Digital Imaging
    • 4.4.2 Analog Imaging
    • 4.4.3 Software Solutions
    • 4.4.4 Radiopharmaceutical Production
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Detectors
    • 4.5.2 Collimators
    • 4.5.3 Data Acquisition Systems
    • 4.5.4 Processing Units
    • 4.5.5 Display Systems
    • 4.5.6 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Cardiology
    • 4.6.2 Oncology
    • 4.6.3 Neurology
    • 4.6.4 Orthopedics
    • 4.6.5 Endocrinology
    • 4.6.6 Nephrology
    • 4.6.7 Gastroenterology
    • 4.6.8 Pulmonology
    • 4.6.9 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Diagnostic Centers
    • 4.7.3 Research Institutes
    • 4.7.4 Academic Institutions
    • 4.7.5 Specialty Clinics
    • 4.7.6 Others
  • 4.8 Market Size & Forecast by Installation Type (2020-2035)
    • 4.8.1 New Installation
    • 4.8.2 Retrofit Installation
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 Inpatient
    • 4.9.2 Outpatient
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Stage (2020-2035)
    • 4.10.1 Preclinical
    • 4.10.2 Clinical
    • 4.10.3 Commercial
    • 4.10.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Installation Type
      • 5.2.1.9 Mode
      • 5.2.1.10 Stage
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Installation Type
      • 5.2.2.9 Mode
      • 5.2.2.10 Stage
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Installation Type
      • 5.2.3.9 Mode
      • 5.2.3.10 Stage
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Installation Type
      • 5.3.1.9 Mode
      • 5.3.1.10 Stage
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Installation Type
      • 5.3.2.9 Mode
      • 5.3.2.10 Stage
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Installation Type
      • 5.3.3.9 Mode
      • 5.3.3.10 Stage
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Installation Type
      • 5.4.1.9 Mode
      • 5.4.1.10 Stage
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Installation Type
      • 5.4.2.9 Mode
      • 5.4.2.10 Stage
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Installation Type
      • 5.4.3.9 Mode
      • 5.4.3.10 Stage
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Installation Type
      • 5.4.4.9 Mode
      • 5.4.4.10 Stage
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Installation Type
      • 5.4.5.9 Mode
      • 5.4.5.10 Stage
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Installation Type
      • 5.4.6.9 Mode
      • 5.4.6.10 Stage
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Installation Type
      • 5.4.7.9 Mode
      • 5.4.7.10 Stage
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Installation Type
      • 5.5.1.9 Mode
      • 5.5.1.10 Stage
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Installation Type
      • 5.5.2.9 Mode
      • 5.5.2.10 Stage
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Installation Type
      • 5.5.3.9 Mode
      • 5.5.3.10 Stage
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Installation Type
      • 5.5.4.9 Mode
      • 5.5.4.10 Stage
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Installation Type
      • 5.5.5.9 Mode
      • 5.5.5.10 Stage
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Installation Type
      • 5.5.6.9 Mode
      • 5.5.6.10 Stage
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Installation Type
      • 5.6.1.9 Mode
      • 5.6.1.10 Stage
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Installation Type
      • 5.6.2.9 Mode
      • 5.6.2.10 Stage
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Installation Type
      • 5.6.3.9 Mode
      • 5.6.3.10 Stage
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Installation Type
      • 5.6.4.9 Mode
      • 5.6.4.10 Stage
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Installation Type
      • 5.6.5.9 Mode
      • 5.6.5.10 Stage

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 GE Healthcare
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Siemens Healthineers
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Philips Healthcare
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Canon Medical Systems
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Fujifilm Holdings Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Hitachi Medical Systems
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Shimadzu Corporation
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Neusoft Medical Systems
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Mediso Medical Imaging Systems
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Digirad Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 SurgicEye
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 CMR Naviscan
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 DDD-Diagnostic
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Sofie Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Medsight Technologies
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Gamma Medica
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Nordion
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Biosensors International
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Positron Corporation
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Cardiarc
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us